SPC296
Glýkópýrróníum eða salt þar af, sérstaklega brómíðsaltið, og indacaterólmaleat, í samsetningu
Status:
AfskrifuðApplication date:
26.5.2020Application published:
15.6.2020Grant published:
15.3.2021
Max expiry date:
22.9.2028Next due date:
31.5.2026Medicine name:
Ultibro BreezhalerMedicine for children:
No
Timeline
Today
26.5.2020Application
15.6.2020Publication
15.3.2021Registration
16.5.2026Expires
Marketing license
IS authorization number:
EU/1/13/862/001-006Date:
15.10.2013
Foreign authorization number:
EU/1/13/862Date:
19.9.2013
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP2228064
Annual fees
Number
Paid
Expires
Payer
Number: 1
Paid: 16.5.2025
Expires: 16.5.2026
Payer: Árnason Faktor ehf.